ARRA INFORMATION

Research Administration Home
Research at UNTHSC Home
Research Administration Staff
Clinical Trials
Laboratory Animal Medicine
Office of Grant and Contract Management
Office for the Protection of Human Subjects
Office of Strategic Research Initiatives
Office of Technology Transfer and Commercialization
Research Committees
Conflict of Interest
Institutional Animal Care and Use
Institutional Biosafety
Institutional Review Board
Research Integrity
Annual Report
COMPLEMENTARY & ALTERNATIVE MEDICINE SHORT-TERM RESEARCH ROTATION
Core Laboratories
Current Intramural Funding Opportunities
Current Training Opportunities
Funding Opportunities
Policies
Research Advisory Committee
Research Advisory Committee Strategic Plan
Research Appreciation Day
University of North Texas Health Science Center’s Annual Research Publication
Upcoming Research Seminars
Contact Us

HIPAA COMPLIANCE INFORMATION

Waiver Request Form
APPLICATION/CERTIFICATION FOR USE AND DISCLOSURE OF
PROTECTED HEALTH INFORMATION FOR RESEARCH
REQUESTING A WAIVER OF AUTHORIZATION

1.    Name(s) of Investigator(s)            Department(s) of Investigator(s)
    ____________________________        _____________________________
    ____________________________        _____________________________
    ____________________________        _____________________________
    ____________________________        _____________________________
    ____________________________        _____________________________

2. Location and brief description of the Protected Health Information
[]  UNTHSC Clinic Records    _________________________________________
[]  UNTHSC Research Records _______________________________________
[]  UNTHSC Other Records (specify) __________________________________
[]  OMCT Medical Records (specify) ___________________________________
[]  OMCT Other Records (specify) _____________________________________
[]  Other (specify)___________________________________________________

3. The investigator(s) seeks the use or disclosure of Protected Health Information (PHI) located at sites indicated in #2, (check one):
    []  Solely for Research on PHI of Decedents
(The investigator will be prepared to provide documentation of the individual’s     death)
[]  Solely to review PHI to prepare a research protocol or for similar purposes     preparatory to research
(The investigator will not remove any PHI from UNTHSC or OMCT in the course of the review)
[]  To use or disclose existing PHI for other research purposes and is requesting a waiver of consent and authorization.

4. How many individual patient records will you access for this protocol? 
   
 
5. State how you will identify protected health information in your research records? (i.e.: name of subjects, coded identifier, etc)





       
 6. Will you be sharing PHI with anyone outside of UNTHSC or OMCT? __yes  __no
If yes, what PHI will be shared and how will it be identified? (i.e: name of subjects, coded identifiers, etc.) ________________________________________________

[NOTE: If the PHI is shared outside of UNTHSC ot OMCT, additional documentation may be necessary to account for the disclosure(s).  Furthermore, the sharing of PHI outside of UNTHSC or OMCT may require the outside party to comply with federal requirements (HIPAA).]

7. Will the PHI you access and record include any of the following elements (check all that apply)?

[]  Patient/Subject Name            []  Device identifiers and serial numbers
[]  Postal address information, other        []  Web Universal Resource Locators   
     than town or city, State & zip code          (URLs)
[]  Telephone numbers            []  Biometric identifiers, including finger
[]  Fax numbers                     and voice prints
[] Electronic Mail addresses            []  Internet Protocol (IP) address numbers
[] Social Security Number            []  Full face photographic images and any
[]  Medical record numbers                 comparable images
[]  Health plan beneficiary numbers        []  Account numbers
[]  Certificate/license numbers        []  None of the above
[]  Vehicle identifiers and serial
      numbers, including license plate
      numbers

8. State how the PHI will be protected from improper use and disclosure:  ____________________________________________________________________________________________________________________________________

9. When will you destroy the PHI? (Be specific; state a date or event, such as following data analysis, following publication, completion of protocol)
   
    ___________________________________________________________________
    ___________________________________________________________________


10. To justify a waiver of the requirement to seek informed consent and/or HIPAA authorization from the subjects, you must be able to answer “YES” to items (a)-(f) below.  Insert explanations that support your request for waiver.

a)     Will the research involve no greater than minimal risk to subjects or to their privacy?    0  yes  0  no
(Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater than those ordinarily encountered in daily life or during the  performance of routine physical or psychological examinations or tests.)
    

b)     Is it true that the waiver will not adversely affect the rights and welfare of subjects?    0  yes  0  no
(Consider the right of privacy and possible risk of breach of confidentiality in light of the information you wish to gather.)
    

c)    Is the risk to privacy reasonable in relation to benefits to be gained or the importance of     0  yes  0  no
the knowledge to be gained?


d)    Would the research be impracticable without the waiver?    0  yes  0  no
(If you checked “yes,” explain how the requirement to obtain consent would make the research impracticable, e.g. are most of the subjects lost to follow-up or deceased?).
    

e)    Would the research be impracticable if you could not record protected    0  yes  0  no
health information (PHI)?
(If you checked “yes,” explain how not recording PHI would make the research  impracticable).
    

f) When appropriate, do you have plans to provide subjects with pertinent information     0  yes  0  no
    after their participation is over? (e.g.  Will you provide details withheld during consent, or tell them if you found information with direct clinical relevance for the subjects?  This may be an uncommon scenario)

I certify that the above information is correct, that it will apply throughout the performance of the proposed research and that I will be responsible for safeguarding the confidentiality of the human subjects who are involved.  I am aware of the confidential nature of the information obtained for the purposes of this research.  No protected health information (PHI) from this research will be shared with or disclosed to others, for purposes other than conducting the research as described above. 

Printed Name:  _______________________________________________
Signature:  __________________________________________________
Date:  ______________________________________________________



 
 
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER at Fort Worth
Center for BioHealth
 3500 Camp Bowie Blvd, Fort Worth, TX 76107-2644
 Phone: (817) 735-5484 Fax: (817) 735-0254
 This page maintained by Brad Anderson.
 For technical problems E-mail the webmaster.
 This page was last updated: 09/09/2009

University of North Texas Health Science Center Homepage Research Office Home Page University of North Texas Health Science Center Homepage